Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

Documenti analoghi

• Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
  di: Pelekanou, Vasiliki, et al.
  Pubblicazione: (2017)
• PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer
  di: Wimberly, Hallie, et al.
  Pubblicazione: (2014)
• Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial
  di: Pelekanou, Vasiliki, et al.
  Pubblicazione: (2018)
• Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
  di: Altan, Mehmet, et al.
  Pubblicazione: (2018)
• B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and Tumor Infiltrating Lymphocytes
  di: Altan, Mehmet, et al.
  Pubblicazione: (2017)